Select Issue
ORIGINAL RESEARCH

Clozapine and hematologic adverse reactions: Impact of the Risk Evaluation and Mitigation Strategy program

PharmD, MBA,
PharmD, and
PhD, MS
DOI: 10.9740/mhc.2020.05.070
PharmD,
PharmD, BCPP,
RPh, and
PharmD, BCPP
PharmD,
PharmD, BCPS, BCPP,
PharmD, BCPS, BCPP, and
PharmD, BCPP

CASE REPORTS
PharmD, BCACP,
PharmD,
PharmD, and
DO, FAWM
,
, and
PharmD, BCPS, BCPP
PharmD,
PharmD, BCPP, and
PharmD, BCPP
PharmD, BCPP and
PharmD

SCIENTIFIC POSTERS